Skip to content
Menu
Menu
Home
About Us
Board & Senior Management
Our Strategy
Midkine
What is Midkine
Extensive Research
Drug Development
International Collaborations
Investors
Regulatory News
Share Capital Information
Corporate Governance
Advisors
Videos
Email Alerts
Corporate Documents
Shareholder Documents
Financial Reports
Presentations
Research Reports
Contact
Menu
Home
About Us
Board & Senior Management
Our Strategy
Midkine
What is Midkine
Extensive Research
Drug Development
International Collaborations
Investors
Regulatory News
Share Capital Information
Corporate Governance
Advisors
Videos
Email Alerts
Corporate Documents
Shareholder Documents
Financial Reports
Presentations
Research Reports
Contact
hostone
ESGCT Edinburgh Conference Poster
13 October 2022
Hybridan LLP – Completion of Oncogeni Acquisition
16 September 2022
Prospectus
13 September 2022
Hybridan LLP – Initiation of Coverage
13 September 2022
12 September 2022
Interim Results to 30 June 2022
26 October 2022
30 June 2022
Proposed Acquisition of Oncogeni & Placing
28 June 2022
23 June 2022
Notice of AGM
13 June 2022
7 June 2022
Optiva Securities – Research Report
19 May 2022
17 May 2022
Investor Presentation
28 March 2022
25 March 2022
Pitt Street Research – Evaluation Report
11 January 2022
Older posts
Page
1
Page
2
…
Page
4
Next
→
STAY INFORMED VIA OUR EMAIL ALERTS
Register
Next Page »
Close
Home
About Us
Board & Senior Management
Our Strategy
Midkine
What is Midkine
Extensive Research
Drug Development
International Collaborations
Investors
Regulatory News
Share Capital Information
Corporate Governance
Advisors
Videos
Email Alerts
Corporate Documents
Shareholder Documents
Financial Reports
Presentations
Research Reports
Contact
hostone
